Table 3.
Frequencies of CCL4 rs1719153 polymorphisms among RA patients, stratified by medications, RF, and ESR status.
| Variables (general population) |
A/A | A/T + T/T | AOR (95% CI) | |
|---|---|---|---|---|
| TNF-α inhibitor | No | 48 | 83 | 1 |
| Yes | 32 | 54 | 0.98 (0.56-1.71) | |
| Methotrexate | No | 38 | 57 | 1 |
| Yes | 43 | 80 | 1.27 (0.73-2.21) | |
| Prednisolone | No | 33 | 65 | 1 |
| Yes | 47 | 72 | 0.78 (0.45-1.36) | |
| RF | Negative | 13 | 20 | 1 |
| Positive | 67 | 117 | 1.14 (0.53-2.43) | |
| ESR (mm/h) | < 20 | 36 | 72 | 1 |
| > 20 | 44 | 65 | 0.74 (0.43-1.29) |
RA: rheumatoid arthritis; RF: rheumatoid factor; ESR: erythrocyte sedimentation rate; CI: confidence interval; AOR: adjusted odds ratio; TNF-α: tumor necrosis factor-alpha.